Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Xeris Pharmaceuticals Inc (XERS)

NASDAQ
Currency in USD
Disclaimer
1.725
-0.035(-1.99%)
Real-time Data

XERS Comments

Anyone think we re gonna see 1.75 soon ?
Another Red day. It's great to buy at these low prices. I just hope it will recover before I run out of money or own it.
Patience is key when investing here. Huge shorting, and FUD it's enough to create doubt. Just remember to DD and you will feel better about your decision
I've been researching this Company all day. Investing now. Here's a link to some info if you're interested.https://1drv.ms/f/s!AtO4hLISyqu2gqAeKyTh59EUVDBCrw
great research. thanks for sharing. I have been buying this stock from $1.9 price onwards. while the company seems to be generating all the right news, we are yet to see all these FDA approvals convert into Revenue and Profits. Hoping 2022 to be the year for that.
great research. thanks for sharing. I have been buying this stock from $1.9 price onwards. while the company seems to be generating all the right news, we are yet to see all these FDA approvals convert into Revenue and Profits. Hoping 2022 to be the year for that.
I bought 44444 at 2.57. Teik proffit - 7.99
I need bitcoin any one have
https://seekingalpha.com/news/3729101-xeris-shares-surge-12-on-fda-greenlight-for-levothyroxine-hypothyroidism-study
Any update about this stock
Only going down. Such a disappointment
Hello to all. I had stocks of Xers a long time ago and I am back to get some now. I saw the earning. What are we waiting regarding the future if someone can summarize. Thanks in advanced
huge uptrend here ... option call strike 10$ with big volume ... no worries next stop 10$-12$ ...
The marketing authorisation is valid in all 27 countries of the European Union, plus Iceland, Norway, and Liechtenstein. As the EC decision was received after the end of the Brexit transition period, Xeris will complete a further administrative step in order to obtain a license in Great Britain. No re-examination of clinical data by the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) is expected.
Lets go!!!!!
Xeris Pharmaceuticals Receives European Commission Approval of Ogluo™ (glucagon) Injection for the Treatment of Severe Hypoglycaemia in Adults, Adolescents, and Children Aged 2 Years and Over With Diabetes Mellitus
why skyrocket?
I wish there is no massive sell off after opening 🙏
I would buy more then. FDA approval by EU happened
target above 10$
XERIS is the 2021 best small cap investment acc. JAMES "REV SHARK" DEPORRE. https://realmoney.thestreet.com/investing/stocks/my-top-small-cap-play-for-2021-15532937?puc=yahoo&cm_ven=YAHOO
Could you drop a link which is working?
not possible here. You can get it directly in the Webull - Xeris stock - news
this will fly. 3 FDA approval for January + partnership for diazepam.
don't stop kitty kitty
go baby go! to the moon
sail away sail away ummmm. enigma
just bought in just bought a ticket for this ride! take off at 9:30 all aboard
Load the Boat
XERS - Xeris Pharmaceuticals Announces Distribution Agreement With Megapharm Ltd. to Commercialize Gvoke in Israel and the Palestinian Authority
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.